Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methenamine hippurate for prevention of recurrent urinary tract infections in elderly women
NL-OMON54960Phase 4Active, not recruiting
- Sponsor
- University of Oslo
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in urinary tract infection (UTI) and cystitis comparing Methenamine hippurate with Placebo (2 arms). Primary endpoint: Number of UTI courses during day 2-180 for which antibiotics were prescribed. Started Nov 2020; status: active, not recruiting.
02
Drugs
methenamine hippurate
03
Conditions
urinary tract infection (UTI)cystitis
Beyond the preview
Go deeper on NL-OMON54960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54960.